Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer have?
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer has 2,916 citations in the OpenAlex counts ScholarIQ stores.
When was Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer published?
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer has 2008 year in the ScholarIQ index.
What is the open-access status of Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer?
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer?
The DOI for Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer is on the source record.
What is the PMID of Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer?
The PMID for Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer is on the source record.
What is the OpenAlex record for Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer?
The OpenAlex for Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer is on the source record.